Compugen (CGEN) Accumulated Expenses (2020 - 2026)

Compugen's (CGEN) quarterly Accumulated Expenses came in at $4.0 million in Q1 2026, down 28.98% quarter-over-quarter from $5.7 million in Q4 2025.

Compugen (CGEN) Accumulated Expenses (2020 - 2026) Analysis & Trends

Compugen has disclosed Accumulated Expenses across 6 years of filings, most recently posting $4.0 million for Q1 2026.

  • Accumulated Expenses for Q1 2026 came in at $4.0 million, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was $4.0 million (changed N/A YoY), and the FY2025 annual result was $5.7 million, up 9.83% from the prior year.
  • Accumulated Expenses came in at $4.0 million for Q1 2026 at Compugen, down from $5.7 million in the prior quarter.
  • In the past five years, Accumulated Expenses ranged from a high of $8.2 million in Q2 2024 to a low of $3.1 million in Q4 2023.
  • The 4-year median for Accumulated Expenses is $5.0 million (2024), against an average of $5.2 million.
  • Across the five-year window, Accumulated Expenses soared 65.38% in 2024 and tumbled 40.01% in 2025, its largest moves.
  • Compugen's Accumulated Expenses stood at $3.1 million in 2023, then surged by 65.38% to $5.2 million in 2024, then grew by 9.83% to $5.7 million in 2025, then decreased by 28.98% to $4.0 million in 2026.
  • The last three Accumulated Expenses figures came in at $4.0 million (Q1 2026), $5.7 million (Q4 2025), and $4.9 million (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn -
7 Psyence Biomedical 212.16 Bn 212.16 Bn -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn
9 Abivax 91.96 Bn 91.96 Bn -
10 Compugen 189.59 Mn 97.83 Mn 352,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 4.03 Mn
Dec 31, 2025 5.68 Mn
Jun 30, 2025 4.93 Mn
Dec 31, 2024 5.17 Mn
Jun 30, 2024 8.22 Mn
Dec 31, 2023 3.13 Mn
Dec 31, 2021 3.30 Mn
Dec 31, 2020 2.88 Mn